GILEAD SCIENCES, INC. — Director's Dealing 2015

May 11, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-05-07

Reporting Person: MILLIGAN JOHN F (President and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-07	Common Stock	M	100000	$14.5025	Acquired	1129108	Direct
2015-05-07	Common Stock	S	26739	$100.3891	Disposed	1102369	Direct
2015-05-07	Common Stock	S	57310	$101.0265	Disposed	1045059	Direct
2015-05-07	Common Stock	S	15951	$101.939	Disposed	1029108	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-07	Non-Qualified Stock Option (right to buy)	$14.5025	M	100000	Disposed	2016-01-25	Common Stock (100000)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F3: Sale prices reported for the transactions reported here range from $99.71 to $100.70. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F4: Sale prices reported for the transactions reported here range from $100.72 to $101.72. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F5: Sale prices reported for the transactions reported here range from $101.73 to $102.26. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.